Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Gains from Investment Securities (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Gains from Investment Securities for 8 consecutive years, with -$390000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 114.29% to -$390000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$594000.0 through Dec 2025, down 873.77% year-over-year, with the annual reading at -$421000.0 for FY2025, 211.8% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$390000.0 at Precision Biosciences, down from $3000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $13.9 million in Q2 2022, with the low at -$626000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $2.0 million, with a median of $91262.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities soared 4080.36% in 2022, then crashed 229.01% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $600000.0 in 2021, then increased by 26.33% to $758000.0 in 2022, then tumbled by 182.59% to -$626000.0 in 2023, then skyrocketed by 70.93% to -$182000.0 in 2024, then crashed by 114.29% to -$390000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$390000.0, $3000.0, and -$25000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.